Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Settles ddRNAi Dispute with Australia s CSIRO and DPI

NEW YORK, Dec. 9 (GenomeWeb News) - Benitec of Queensland, Australia, yesterday said that it had settled an intellectual property dispute with Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO) and the Queensland Department of Primary Industries (Queensland DPI), regarding commercialization of DNA-Directed RNA interference, or ddRNAi.

Under the terms of the agreement, Benitec will focus on commercializing ddRNAi for human applications, including research models used in functional genomics, while CSIRO will commercialize non-human applications, including plants, animals, and insects. Queensland DPI will continue its ddRNAi research and will have access to both Benitec's and CSIRO's commercialization routes.

Benitec and CSIRO will share revenues generated from the commercial applications of ddRNAi, and each party will retain the majority of revenue generated from its respective application area.

Benitec was awarded its first US Patent for its ddRNAi technology in June.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.